It is a drug used in benign prostatic hypertrophy which acts as a selective ?1-adrenergic receptor antagonist or alpha blocker.
Naftopidil
Naftopidil; 57149-07-2; Flivas; KT-611; Avishot; Naftopidilum [Latin]
Nafodil, Naftomax
1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-(naphthalen-1-yloxy)propan-2-ol
NA
NA
NA
Naftopidil, a novel alpha-1 adrenoreceptor antagonist, is prescribed for the treatment of benign prostatic hyperplasia (BPH)
NA
Naftopidil may interact with indapamide and its analogues.
Naftopidil is contraindicated in patients with orthostatic hypotension, salt imbalance, women and children.
NA
392.499
C24H28N2O3
57149-07-2
NA